Is Seer Inc (SEER) overvalued? · rev $14.2M
Seer Inc (SEER) is a biotechnology company listed on NASDAQ.
This page asks whether Seer Inc (SEER) looks expensive on cached numbers — not a short thesis.
Latest reported SEER revenue for 2024-12-31 was $14.2M. Net income was -$86.6M. Revenue was down 15.0% from 2023-12-31 to 2024-12-31. SEER currently screens at market cap $94.6M.
SEER currently screens at market cap $94.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SEER 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SEER stock page for the full model, not this heading.
Not investment advice.